++++++++ REVIEW: LIVe 2024 in Nice/France was very lively
It was great to meet so many VITROCELL users and interested researchers for the Air/Liquid Interface exposure! The combination with the VITROCELL User Group Meeting 2024 brought an extremely valuable experience exchange among the participants at our booth and during the poster sessions.
Thank you to all presenters for making reference to VITROCELL equipment: Claus-Michael Lehr (Universität des Saarlandes); Yvonne Staal (National Institute for Public Health and the Environment (RIVM)); Barbara Rothen-Rutishauser (Université de Fribourg/Universität Freiburg); Sabina Burlă and Arno Gutleb (Luxembourg Institute of Science and Technology (LIST)) and invitrolize); Sarah Wideman (G.ST Antivirals ); Aurelia Alumni (Ineris – Institut national de l’environnement industriel et des risques); Nuria Roldan and Andreas Stucki (PETA Science Consortium International e.V..); Giulia Raggi (AlveoliX ); Michael Hollings (Labcorp Drug Developement.) and Mathilde Delaval (Helmholtz Munich).
The discussions at the booth have been valuable for us – thank you to all visitors.
Epithelix and ALTERTOX did a fantastic job in organizing the conference. We can’t wait for the next event in 2 years. Special thanks also to Jos van Triel to organize a workshop on ALI exposure methods at RIVM later this year!
++++++++
+++ LUNG IN VITRO event LIVe 2024, Program is now online: >> Program +++
Many thanks to Altertox and Epithelix for organizing this outstanding event.
LIVe2024 intends to be a unique exchange platform for scientists interested in in vitro respiratory researches, stakeholders from academia, pharma, biotech, chemical, tobacco, consumer goods, medical devices industries, CROs and regulatory agencies.
The meeting focuses on predictive in vitro lung models designed for basic research, efficacy and toxicity testing. It aims to present the state-of-art of in vitro lung models, and to map out the route for its future development and use.
For more detailed information please visit the following page: LIVe2024
